| pubmed-article:11250974 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0162577 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0016011 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0851347 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C1416485 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0665278 | lld:lifeskim |
| pubmed-article:11250974 | lifeskim:mentions | umls-concept:C0439608 | lld:lifeskim |
| pubmed-article:11250974 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11250974 | pubmed:dateCreated | 2001-3-19 | lld:pubmed |
| pubmed-article:11250974 | pubmed:abstractText | Lefradafiban is the orally active prodrug of fradafiban, a glycoprotein IIb/IIIa receptor antagonist. The present phase II study aimed to determine the dose of lefradafiban that provides 80% blockade of the glycoprotein IIb/IIIa receptors by fradafiban, and to study the pharmacodynamics and safety of different doses in patients with stable angina undergoing angioplasty. | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11250974 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11250974 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11250974 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11250974 | pubmed:issn | 1468-201X | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:HoffmannJJ | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:SimoonsM LML | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:DeckersJ WJW | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:StibbeJJ | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:SuryapranataH... | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:PeelsH OHO | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:BaardmanTT | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:AkkerhuisK... | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:van Den... | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:van Der... | lld:pubmed |
| pubmed-article:11250974 | pubmed:author | pubmed-author:van Der... | lld:pubmed |
| pubmed-article:11250974 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:11250974 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:11250974 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11250974 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11250974 | pubmed:pagination | 444-50 | lld:pubmed |
| pubmed-article:11250974 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:meshHeading | pubmed-meshheading:11250974... | lld:pubmed |
| pubmed-article:11250974 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11250974 | pubmed:articleTitle | Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. | lld:pubmed |
| pubmed-article:11250974 | pubmed:affiliation | Thoraxcenter, Erasmus University and University Hospital Rotterdam, Netherlands. makkerhuis@cardialysis.nl | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:11250974 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
